Inhibitory effects of multi-substituted benzylidenethiazolidine-2,4-diones on LDL oxidation

被引:53
作者
Jeong, TS
Kim, JR
Kim, KS
Cho, KH
Bae, KH
Lee, WS [1 ]
机构
[1] Korea Res Inst Biosci & Biotechnol, Natl Res Lab Lipid Metab & Atherosclerosis, Taejon 305333, South Korea
[2] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea
关键词
antioxidant;
D O I
10.1016/j.bmc.2004.06.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multi-substituted benzylidenethiazolidine-2,4-diones 3a-h were synthesized by Knoevenagel condensation of di- or tri-substituted 4-hydroxybenzaldehydes [or 1-(3,5-di-tert-butyl-4-hydroxyphenyl)ethanone] 1 with thiazolidine-2,4-dione (2) and evaluated for antioxidant activities of Cu2+-induced oxidation of human low-density lipoproteins (LDL). Among compounds 3a-h, 3a was superior to probucol in LDL-antioxidant activities and found to be ninefold more active than probucol. Due to its potency, compound 3a was tested for complementary in vitro investigations, such as TBARS assay (IC50 = 0.1 muM), lag time (240 min at 1.5 muM), relative electrophoretic mobility (REM) of ox-LDL (inhibition of 83% at 10 muM), fragmentation of apoB-100 (inhibition of 61% at 5 muM), and radical DPPH scavenging activity on copper-mediated LDL oxidation. In macro phage-mediated LDL oxidation, the TBARS formation was also inhibited by compound 3a. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4017 / 4023
页数:7
相关论文
共 33 条
[1]   THE ANTIOXIDANT BUTYLATED HYDROXYTOLUENE PROTECTS AGAINST ATHEROSCLEROSIS [J].
BJORKHEM, I ;
HENRIKSSONFREYSCHUSS, A ;
BREUER, O ;
DICZFALUSY, U ;
BERGLUND, L ;
HENRIKSSON, P .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :15-22
[2]   ANTIOXIDANT DETERMINATIONS BY THE USE OF A STABLE FREE RADICAL [J].
BLOIS, MS .
NATURE, 1958, 181 (4617) :1199-1200
[3]   4-THIAZOLIDINONES [J].
BROWN, FC .
CHEMICAL REVIEWS, 1961, 61 (05) :463-521
[4]  
Brown JE, 1998, BIOCHEM J, V330, P1173
[5]  
BUTTRISS JL, 1984, METHOD ENZYMOL, V105, P131, DOI 10.1016/S0076-6879(84)05018-7
[7]   PROBUCOL ATTENUATES THE DEVELOPMENT OF AORTIC ATHEROSCLEROSIS IN CHOLESTEROL-FED RABBITS [J].
DAUGHERTY, A ;
ZWEIFEL, BS ;
SCHONFELD, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (02) :612-618
[8]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[9]   DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353
[10]  
HEINECKE JW, 1987, J BIOL CHEM, V262, P10098